News

Deal Announcements

Eureka Finds Second Venture Capital Round

Tuesday, November 18, 2008 5:38:00 AM PDT | VentureDeal Staff
Emeryville, California  --  Biotechnology company Eureka Therapeutics has raised $6 million in its series B round of investment, according to a report in VentureWire.

Eureka has developed technologies and services for customers pursuing therapeutic antibody treatment research.

Investors in the round were not disclosed, nor were the proceeds from the funding.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1